PlexusDx vs PlushCare: GLP-1 Programs Compared Head-to-Head (2026)

Last reviewed: September 8, 2026 Last updated: September 8, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

PlushCare and PlexusDx operate fundamentally different GLP-1 business models. PlushCare is a clinical telehealth service that prescribes brand-name medications—Wegovy, Ozempic, Zepbound, Mounjaro, Saxenda—and sends prescriptions to external pharmacies; you pay membership and visit fees to PlushCare, then pay for medication separately at the pharmacy. PlexusDx is a direct-dispense compounded-medication program with flat monthly all-inclusive pricing that covers the provider review, compounded semaglutide or tirzepatide, and shipping in one published figure.

The comparison turns on two questions: Do you want brand-name FDA-approved drugs and are willing to navigate insurance, prior authorization, and variable pharmacy pricing? Or do you want fixed-cost compounded medication with no insurance required and total transparency at enrollment?

At-a-glance comparison

PlushCare membership and clinical fees (medication paid separately)

PlushCare charges a membership fee and a separate initial-visit fee. Medication is not included in either; you pay for it at an external pharmacy after the provider writes the prescription.

Membership pricing (verified September 4, 2026):

• First 30 days: free trial
• Monthly plan: $19.99/month after the trial
• Annual plan: $149 prepaid upfront, equal to $12.42/month (our calculation)
• Cancellation: anytime, no minimum commitment documented

Initial provider visit: $129 self-pay (one-time in year one). Follow-up visit pricing not published in verified sources.

Total service-layer cost, first 12 months (our calculation):

• Monthly membership path: $0 (month 1 free) + 11 × $19.99 + $129 visit = $348.89
• Annual membership path: $149 (year 1 prepaid) + $129 visit = $278

These totals cover only PlushCare's clinical service. Medication, labs, and pharmacy fees are additional and variable.

PlushCare medication cost: why it is not published

PlushCare prescribes brand-name GLP-1s—Wegovy, Ozempic, Zepbound, Mounjaro, Saxenda—and sends the prescription to an external pharmacy of the patient's choice. The patient pays the pharmacy directly. According to PlushCare's published service documentation (captured September 4, 2026), "medication price depends on pharmacy/coverage." The medication cost depends on:

• Your insurance plan and whether the prescribed drug is on formulary
• Copay tier (brand-name GLP-1s often sit in specialty tiers with high copays or coinsurance)
• Prior authorization approval (PlushCare offers PA support, but approval is not guaranteed)
• Pharmacy pricing (retail chains, mail-order, discount programs, manufacturer savings cards)
• Which specific drug the provider prescribes

Because PlushCare does not sell medication, it does not publish medication pricing. This is standard for prescription-facilitation telehealth services.

The result: total monthly cost is unknowable until after the clinical visit, prescription, pharmacy selection, and insurance adjudication. For patients with comprehensive insurance and prior authorization approval, the medication may cost less than compounded alternatives; for self-pay patients or those whose insurance denies coverage, brand-name GLP-1 retail prices can exceed $1,000/month per drug.

PlexusDx compounded GLP-1 pricing (medication included, month-to-month and prepaid)

PlexusDx publishes flat monthly pricing that includes the compounded medication, provider review, and shipping. There is no separate membership fee, no separate visit fee, and no insurance required. The price you see is the price you pay, and it does not change with dose escalation.

Compounded semaglutide injection (verified September 8, 2026):

• Month-to-month: $189/month
• 3-month plan: $169/month ($507 prepaid per quarter)
• 6-month plan: $149/month ($894 prepaid per half-year)

Compounded tirzepatide injection:

• Month-to-month: $289/month
• 3-month plan: $269/month ($807 prepaid per quarter)
• 6-month plan: $249/month ($1,494 prepaid per half-year)

Compounded semaglutide oral:

• Month-to-month: $289/month
• 3-month plan: $269/month ($807 prepaid per quarter)
• 6-month plan: $249/month ($1,494 prepaid per half-year)

Compounded tirzepatide oral:

• Month-to-month: $349/month
• 3-month plan: $299/month ($897 prepaid per quarter)
• 6-month plan: $279/month ($1,674 prepaid per half-year)

Microdose GLP-1 (maintenance protocol):

• Month-to-month: $129/month

All prepaid per-month figures are our calculation. Multi-month plans require upfront payment for the full term.

12-month cost comparison: what we can and cannot calculate

A fair total-cost comparison requires knowing medication cost for both programs. For PlexusDx, medication is included in the published monthly price. For PlushCare, medication is paid separately at an external pharmacy, and the cost is variable and unpublished.

PlexusDx 12-month cost (all-inclusive, our calculation):

• Semaglutide injection MTM: 12 × $189 = $2,268
• Semaglutide injection 6-month plan: 12 × $149 = $1,788 (prepaid in two 6-month cycles)
• Tirzepatide injection MTM: 12 × $289 = $3,468
• Tirzepatide injection 6-month plan: 12 × $249 = $2,988 (prepaid in two 6-month cycles)

These figures cover medication, provider access, and shipping for the full year.

PlushCare 12-month cost (service layer only, our calculation):

• Monthly membership path: $348.89 (membership + initial visit, no medication or labs)
• Annual membership path: $278 (membership + initial visit, no medication or labs)

To calculate PlushCare's total cost, you must add:

• Medication cost (brand-name GLP-1 at external pharmacy, 12 months)
• Lab cost (if required, not included)
• Any follow-up visit fees (pricing not documented)

Because PlushCare's medication cost is variable—determined by insurance coverage, prior authorization outcome, copay tier, and pharmacy selection—we cannot produce a comparable 12-month all-in figure. If your insurance covers the prescribed brand-name drug with a low copay and prior authorization is approved, PlushCare's total cost may be lower than PlexusDx. If you are self-pay or insurance denies coverage, retail brand-name GLP-1 pricing (often $900–$1,300+/month per drug, depending on the specific medication and pharmacy) will substantially exceed compounded medication cost.

Structural differences: prescription facilitation vs direct compounded dispensing

PlushCare's model: You pay PlushCare for membership and clinical visits. The provider writes a prescription for a brand-name FDA-approved GLP-1 (Wegovy, Ozempic, Zepbound, Mounjaro, or Saxenda). The prescription is sent to an external pharmacy—retail, mail-order, or specialty—where you pay for the medication separately. PlushCare does not compound or dispense medication. Total cost transparency is limited because medication pricing depends on external variables (insurance, pharmacy, prior authorization). PlushCare offers prior-authorization support to help navigate insurance requirements.

PlexusDx's model: You pay PlexusDx one flat monthly price that includes the compounded semaglutide or tirzepatide medication, provider review and access, and shipping. PlexusDx works with licensed 503A compounding pharmacies to prepare and dispense the medication directly. No insurance is required, no prior authorization, no separate pharmacy step. Total cost is known at enrollment and does not change with dose escalation. The trade-off: compounded medications are not FDA-approved (see disclosure below).

The choice between these models often comes down to: Do you have insurance that covers brand-name GLP-1s, and are you willing to manage prior authorization and variable pharmacy pricing in exchange for an FDA-approved drug? Or do you prefer fixed-cost simplicity and immediate medication access, accepting that the medication is compounded rather than FDA-approved?

Decision factors

PlushCare's advantages:

• Brand-name FDA-approved medications: Wegovy, Ozempic, Zepbound, Mounjaro, and Saxenda are FDA-reviewed for safety, effectiveness, and quality before marketing.
• Insurance compatibility: If your plan covers GLP-1s for weight management and prior authorization is approved, your out-of-pocket medication cost may be lower than self-pay compounded options.
• Prior-authorization support: PlushCare assists with the PA process, which can be complex and time-consuming when navigating insurer requirements independently.
• Low service-layer cost: Membership and initial visit fees total $278–$349 for year one, lower than many telehealth competitors' membership structures.
• No minimum commitment: Cancel the membership anytime.

PlushCare's limitations and uncertainties:

• Medication cost unknown until after enrollment: Total expense depends on insurance adjudication, prior authorization approval, copay tier, and pharmacy pricing—none of which are knowable at signup.
• Insurance denial risk: Many insurers deny GLP-1 coverage for weight management or require documented failed attempts at other weight-loss methods. If denied, you pay retail brand-name pricing out-of-pocket or do not fill the prescription.
• High self-pay brand-name cost: Retail pricing for Wegovy, Ozempic, Zepbound, Mounjaro, and Saxenda often exceeds $900/month, and some drugs approach or exceed $1,300/month, depending on the pharmacy and any manufacturer discount programs.
• No compounded medication option: If you want lower-cost compounded semaglutide or tirzepatide, PlushCare does not offer it.
• Labs not included: Baseline and monitoring labs are an extra cost.

PlexusDx's advantages:

• Total cost transparency: The published monthly price is the full cost—medication, provider access, shipping included—and you know it before enrollment.
• No insurance required: No prior authorization, no copay variability, no denial risk.
• Fixed dosing cost: The monthly price does not increase when your dose escalates.
• No membership fee: One all-in monthly medication price; no separate membership or visit charges.
• Multiple medication options: Compounded semaglutide and tirzepatide in both injection and oral forms, plus a microdose maintenance protocol.
• Multi-month discounts: Prepaid 3-month and 6-month plans reduce the effective monthly rate (semaglutide injection as low as $149/month on the 6-month plan, tirzepatide injection as low as $249/month).
• Verified review record: PlexusDx holds a 4.3-star rating on Trustpilot, with 79% of reviews at five stars and 83% at four stars or higher (captured September 9, 2026).

PlexusDx's limitations:

• Compounded medications are not FDA-approved: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient.
• No insurance accepted: Compounded medications are typically not covered by insurance; all cost is out-of-pocket.
• Prepayment required for multi-month plans: The discounted 3-month and 6-month rates require upfront payment for the full term.

Choose PlushCare if…

You want a brand-name FDA-approved GLP-1 medication and have insurance that you believe will cover it. You are willing to navigate the prior-authorization process (with PlushCare's support) and accept that your total monthly cost will not be known until after insurance adjudication and pharmacy selection. You prefer working with your existing pharmacy and want the option to use manufacturer savings cards or patient-assistance programs tied to brand-name drugs. You value FDA review of the medication before marketing and are prepared for the possibility that insurance may deny coverage, leaving you with high retail self-pay costs or no prescription fill.

Choose PlexusDx if…

You want fixed-cost compounded semaglutide or tirzepatide with total transparency at enrollment—no insurance required, no prior authorization, no variable pharmacy pricing. You prefer an all-in-one program where medication, provider access, and shipping are covered by a single published monthly price that does not change as your dose increases. You are comfortable with compounded medication (not FDA-approved) in exchange for lower cost and simpler logistics. You want the option to lock in a lower effective monthly rate with a prepaid multi-month plan, or you prefer the flexibility of month-to-month billing with no long-term commitment.

Methodology and freshness

PlushCare membership pricing, visit fees, medication model, product offerings, prior-authorization support, and cancellation terms verified from the provider's public website and service documentation, captured September 4, 2026. PlexusDx pricing, product catalog, inclusions, and dose-pricing policy verified from plexusdx.com and internal product data, captured September 8, 2026. PlexusDx Trustpilot rating (4.3 stars, 79% five-star, 83% four-star or higher) verified September 9, 2026.

All 12-month cost calculations, prepaid per-month amounts, and service-layer totals are our calculation based on the verified per-period rates. PlushCare medication cost is not calculable from available evidence because medication is purchased at external pharmacies and pricing depends on insurance coverage, prior authorization outcome, copay tier, and pharmacy selection—all patient-specific variables not published by PlushCare.

We model representative scenarios (monthly vs annual membership, service fees only) to illustrate the knowable cost components. We do not speculate about brand-name medication retail pricing ranges beyond noting that self-pay patients face substantially higher costs than insured patients with prior-authorization approval. Readers should confirm current pricing, insurance coverage, and prior-authorization requirements at enrollment, as all figures are point-in-time observations and subject to change.

Frequently Asked Questions

What is the real monthly cost difference between PlushCare and PlexusDx?

PlushCare's service fees are lower ($278–$349 for year one, covering membership and initial visit), but medication is paid separately at an external pharmacy and the cost is variable and unpublished. PlexusDx's monthly price ($189–$349 depending on medication and plan) is all-inclusive. If your insurance covers the brand-name GLP-1 with a low copay, PlushCare may cost less; if you are self-pay or insurance denies coverage, PlexusDx's fixed compounded-medication pricing is typically lower than brand-name retail rates.

Does PlushCare include medication in its membership fee?

No. PlushCare's membership ($19.99/month after a 30-day free trial, or $149/year prepaid) and initial visit fee ($129) cover only the clinical telehealth service. Medication is prescribed by the provider and filled at an external pharmacy, where you pay separately. The medication cost depends on your insurance coverage, copay tier, prior authorization approval, and the pharmacy you choose.

Will PlushCare help with prior authorization if my insurance requires it?

Yes. PlushCare offers prior-authorization support to help navigate insurer requirements for brand-name GLP-1 coverage. However, prior authorization approval is not guaranteed—insurers may deny coverage based on their formulary rules, medical-necessity criteria, or requirements for documented failed weight-loss attempts. If denied, you pay retail brand-name pricing out-of-pocket or do not fill the prescription.

Does PlushCare offer compounded semaglutide or tirzepatide?

No. PlushCare prescribes only brand-name FDA-approved GLP-1 medications: Wegovy, Ozempic, Zepbound, Mounjaro, and Saxenda. If you want compounded semaglutide or tirzepatide at a lower fixed monthly cost, PlushCare does not offer that option; you would need a provider like PlexusDx that works with licensed compounding pharmacies.

Can I use insurance with PlexusDx compounded GLP-1 programs?

No. PlexusDx dispenses compounded semaglutide and tirzepatide, which are typically not covered by insurance. All cost is out-of-pocket. The trade-off is fixed monthly pricing with no prior authorization required and total cost transparency at enrollment—you know exactly what you will pay each month before you start.

Sources

• PlexusDx product catalog and pricing, plexusdx.com, accessed September 8, 2026
• PlushCare service model, medication offerings, and prescription process, plushcare.com, captured September 4, 2026
• PlushCare membership pricing, visit fees, labs policy, and cancellation terms, plushcare.com, captured September 4, 2026
• PlexusDx Trustpilot rating and review distribution, trustpilot.com, accessed September 4, 2026
• PlushCare public service verification, plushcare.com, captured September 4, 2026

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. PlexusDx works with licensed 503A compounding pharmacies. A licensed clinician determines whether a prescription is appropriate for an individual patient.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.